Navigation Links
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Date:7/1/2009

ld continue to serve as an inspiration to the scientific community as we carry on with our quest to care for the world, one patient at a time."

Nominations for the 2010 Dr. Paul Janssen Award will open in September and submission details will be announced at that time.

* Herceptin is a registered trademark of Genentech, Inc.

About The Dr. Paul Janssen Award

Established by Johnson & Johnson, The Dr. Paul Janssen Award salutes the most passionate and creative scientists in basic or clinical research whose scientific achievements have made, or have strong potential to make, a measurable impact on human health. The Dr. Paul Janssen Award is named for Dr. Paul Janssen, who founded Janssen Pharmaceutica, N.V. in 1953. Known to his colleagues as "Dr. Paul," Janssen was one of the 20th century's most gifted and passionate researchers, a physician-scientist who helped save millions of lives through his contribution to the discovery and development of more than 80 medicines, of which four are on the World Health Organization's list of essential medicines. In 1961, Janssen Pharmaceutica, N.V. joined the Johnson & Johnson Family of Companies. Janssen's legacy continues to inspire Johnson & Johnson and its commitment to finding innovative cures for unmet medical needs. Visit www.pauljanssenaward.com for more information.

About the Selection Committee

The Dr. Paul Janssen Award independent Selection Committee is composed of some of the world's leading scientists, including National Medal of Science winners, Nobel Laureates, members of the National Academy of Sciences and past winners of The Dr. Paul Janssen Award. The 2009 Selection Committee includes:

  • Solomon Snyder, M.D., (chairman) distinguished service professor of Neuroscience, Pharmacology and Psychiatry, '/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
2. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
3. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
4. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
5. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
7. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
9. Video: Keppra XR(TM) Approved in the U.S.
10. Video: Fortune 1000 Executives: New President Must Fix Education Gap
11. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... TRANSPORTATION -- Gone hybrid . . . , Fuel e...iles are now posted at the www.fueleconomy.gov w...oped and maintains for the U.S. Department of Ener...ine of the top 10 vehicles on the best fuel econom...us (51 MPG city; 48 highway). "This list proves th...
(Date:11/5/2009)..., SAN DIEGO, Nov. 5 Ima...d today that William Spencer, President and CEO of...y at the 2nd annual LD MICRO Conference on Thursda...t in Los Angeles. ,, About LD MICRO ,, LD MI...ocuses on finding undervalued companies in the mic...
(Date:11/5/2009)..., LYNBROOK, N.Y., Nov. 5 /PRNewswire-FirstCall/ -..., a biopharmaceutical company developing first-in-...its financial results for the third quarter ended ...y that, in September of this year, the FDA,s Arthr...y a vote of 12-0, the approval of XIAFLEX(TM) for ...
(Date:11/5/2009)..., FREMONT, Calif., Nov. 5 /PRNewswire-FirstCall/ ...WGBS), a leading developer of state-of-the-art gen...opher Sears, Ph.D. has joined the company,s Scient...on designing and commercializing novel molecular d...ions, and on the development of computational biol...
Breaking Biology Technology:November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
...onsecutive Quarter of Profitability, OMAHA, Neb.,...oday announced financial results for the quarter,e...e of $101,000, or $0.00,per share, in the second q... $0.00 per share, in the year ago period., The se...rd consecutive,quarter of profitability from conti...
...s increase 107% over Second Quarter 2007, EMERYVI...asdaq: ONXX ) today reported its financial result.... Onyx reported net income,of $4.5 million, or $0....08,compared to a net loss of $10.8 million, or $0....Excluding employee stock-based compensation expens...
...5 Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ) to...ter,ended June 30, 2008., Total revenues in the s...o $4.8 million in the second quarter of 2007, and ...tract manufacturing agreement with,Siegfried Ltd a...a,s,collaborations with Merck & Co., Inc. and Orth...
Other Biology Technology:Transgenomic Reports Second Quarter 2008 Results 2Transgenomic Reports Second Quarter 2008 Results 3Transgenomic Reports Second Quarter 2008 Results 4Transgenomic Reports Second Quarter 2008 Results 5Transgenomic Reports Second Quarter 2008 Results 6Transgenomic Reports Second Quarter 2008 Results 7Transgenomic Reports Second Quarter 2008 Results 8Transgenomic Reports Second Quarter 2008 Results 9Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 2Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 3Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 4Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 5Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 6Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 7Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 8Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 9Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 10Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 2Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 3Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 4Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 5Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 6Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 7Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 8Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights 9
(Date:11/4/2009)... , United States Using Less Water Today , Th...35 years ago, despite a 30 percent population incr...e to alternative cooling methods at power plants a... the latest USGS water use report, nearly half of ...g thermoelectric power plants. Irrigation accounts...
(Date:11/4/2009)... received more than $10 million in research grants... stimulus program, bringing thetotal amount of sti...llion. Thirty-three projects achieved stimulus fu...her. , "The university has thoughtfully undertak...arly excellence to federal agency priorities. Thr...
(Date:11/4/2009)... What,s the cost of saving a teenage life? When it...om prescription medication abuse, there,s no price...e unaware that the lock-boxes they,ve installed ar...bomb of prescription drugs. That,s why MEDNET(TM),...lies, has formed an exclusive partnership with Axi...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Bone Safety 101 54462 1BIG research offers insight into aging 2 scientists awarded 24200 000 prize 54457 1BIG research offers insight into aging 2 scientists awarded 24200 000 prize 54457 2Brain innately separates living and non living objects for processing 9565 1Brain innately separates living and non living objects for processing 9565 2
... meerkats subject their subordinates to escalating... become overly stressed and as a result infertile,...at during the latter half of her pregnancy, the do...er subordinate females from the group for an avera...nates, typically those with whom reproductive conf...
...researchers has found that people with long-standi...rea of the brain responsible for voluntary movemen...ted out of the brain to a computer and converted i...form basic tasks. , In the 13 July 2006 issue of...ed results from the initial participants in a clin...
...am who - 10 years ago - created the cloned sheep "...n of Pharmaceutical Scientists, (AAPS) National Bi...the meeting, nearly two-thousand of the world,s le...l issues affecting pharmaceutical biotechnology in...as the next revolution in healthcare. , "At AAPS, ...
Other Biology News:Dominant meerkats render rivals infertile 2Brain-computer link lets paralyzed patients convert thoughts into actions 2Brain-computer link lets paralyzed patients convert thoughts into actions 3Brain-computer link lets paralyzed patients convert thoughts into actions 4Brain-computer link lets paralyzed patients convert thoughts into actions 5Ten years later, Dolly is still making headlines 2
Conditioned Media Production Services from ARVYS Proteins, Inc.
...rs SNP loci identification through targeting reseq...sign, intensive assay validation/optimization, hig...or customer-supplied samples and sequence alignmen...provides for rapid and highly accurate identificat...
Pre-Validated Kinase Polymorphism Assays from Agencourt Bioscience
...n aqueous-based mounting medium designed for the p...s. Gel/Mount is especially recommended when using ...ophycocyanin or FluoroBlue. It can also be used wi...scein (FITC), Rhodamine (TMRITC) and Texas Red. Ge...
Biology Products: